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To the Editor:
Growing evidence indicates that ele-vated levels of the liver enzymes 
γ-glutamyltransferase (GGt), aspar-
tate transaminase (ASt), and alanine 
transaminase (ALt) are independently 
associated with increased risk of cardio-
vascular disease (CVD).1–4 GGt may 
also increase due to environmental pol-
lution.1 Ambient particulate matter has 
been shown to induce oxidative stress 
and being linked to CVD5 and might 
potentially affect liver enzymes’ levels. 
therefore, we assessed the association 
between chronic ambient air pollution 
and serum liver enzymes, as a possible 
component in the mechanisms linking 
air pollution to CVD.
We analyzed data collected in two 
KOrA (Cooperative Health research in 
the region of Augsburg) surveys, con-
ducted in Augsburg and two adjacent 
counties in southern Germany between 
2004 and 2008. Blood was drawn from 
5,892 adults aged 31 to 85 years, and 
the serum liver enzymes GGt, ASt, and 
ALt were analyzed. Air pollution expo-
sure was estimated within the eSCAPe 
study (european Study of Cohorts for 
Air Pollution effects, http://www.esca-
peproject.eu/) between 2008 and 2009 
by a combination of measurements and 
modeling. We estimated the annual 
average concentrations of particles below 
2.5 µm (PM2.5), below 10 µm (PM10), 
coarse particles (PMcoarse), absorbance 
of PM2.5, nitrogen oxides (NOx), and 
nitrogen dioxide (NO2) at the residential 
address of each participant. We assessed 
the associations by multivariable linear 
models with log-transformed outcome 
variables. All models were adjusted for 
socioeconomic, lifestyle, and clinical 
covariates. For a detailed description of 
the outcome and exposure variables as 
well the covariates see the eAppendix 
(http://links.lww.com/eDe/A717).
Percent changes of liver enzymes 
means associated with an increase in 
air pollutants from 5% of the distri-
bution to 95% are shown in the table. 
For GGt, elevated levels of pollutants 
were associated with increased mean 
serum level, most strongly for PM2.5. 
An increase of the annual average con-
centration of PM2.5 at residences of 
2.77 µg/m3 (5%–95% range) increased 
mean serum concentration of GGt 
among the study participants by 5.1% 
(95% confidence interval = 0.1% to 
10.4%). the association was stron-
ger for participants with CVD (12.0% 
[4.4% to 20.2%]), whereas those with-
out CVD showed no association. For 
ASt and ALt, we observed no consis-
tent patterns.
One biological insight into the 
association of serum GGt and CVD 
induction is a possible role of GGt in 
oxidative stress.1 GGt is present in ath-
erosclerotic plaques and may catalyze 
oxidation of low-density lipoproteins, 
contributing to plaque evolution and 
rupture.1 Also, GGt acts as a protein 
catalyst in the catabolism of glutathione, 
the major thiol antioxidant in the body.1 
the role of GGt in oxidative stress and 
in the progression of atherosclerosis 
has been supported by the association 
with carotid intima-media thickness.2,4,6 
Moreover, GGt is more strongly asso-
ciated with cardiovascular outcomes 
than ALt,1,7 which is considered to be a 
marker of liver injury but not of oxida-
tive stress.1
thus, our findings concerning 
GGt may strengthen the hypothesis that 
particulate air pollution affects the car-
diovascular system through mechanisms 
related to systemic oxidative stress. As 
correlations between PM2.5 and other 
pollutants were weak, this suggests that 
the pathway of PM2.5 might differ from 
the pathways of other pollutants. For 
example, PM2.5 can penetrate deeper 
into the pulmonary tree compared with 
PM10 or PMcoarse because of its smaller 
aerodynamic diameter. Additionally, 
our finding regarding strong effect 
modification by CVD might indicate 
that people with CVD are more sus-
ceptible to air pollution. However, as 
our reported association has not been 
assessed previously, it has to be repli-
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GGT of Change 
(95% CI)
AST of Change 
(95% CI)
ALT of Change 
(95% CI)
PM2.5 (µg/m
3) 2.8 5.1 (0.1 to 10.4) 0.7 (−1.6 to 3.0) −1.0. (−4.4 to 2.6)
PM10 (µg/m
3) 7.7 3.8 (−1.3 to 9.1) 0.3 (−2.0 to 2.7) 0.6 (−3.0 to 4.2)
PMcoarse (µg/m
3) 3.5 3.5 (−1.7 to 8.9) −0.4 (−2.7 to 2.0) 0.4 (−3.2 to 4.1)
PM2.5 absorbance (10
−5 m−1) 0.5 1.9 (−3.1 to 7.1) −0.4 (−2.6 to 2.0) −1.0 (−4.5 to 2.6)
NOx (µg/m
3) 22.3 2.5 (−2.4 to 7.6) −0.2 (−2.4 to 2.1) 1.2 (−2.3 to 4.7)
NO2 (µg/m
3) 11.8 3.0 (−2.0 to 8.1) 0.5 (−1.8 to 2.8) 2.5 (−1.0 to 6.1)
CI indicates confidence interval.
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the case-population ratio is per-
pendicular to the rr: rather than the 
ratio of case rates among exposed and 
unexposed, it is the ratio of exposure 
rates among cases and population. In the 
usual two-by-two table (table), where 
a is the number of exposed cases, b the 
number of exposed noncases, c the num-
ber of unexposed cases, and d the number 
of unexposed noncases, rr is (a/a+b)/
(c/c+d), Or is a/c/b/d (or ad/bc), and 
case-population ratio is (a/a+c)/((a+b)/
(a+b+c+d)). the analysis population 
may come from a representative popu-
lation sample with a known sampling 
rate or from representative samples with 
unknown sampling rates (eg, the UK 
Clinical Practice research Datalink). In 
that case, case-population ratio could be 
expressed as (a/(a+c))/((e/e+f)), where 
e and f are the exposed and unexposed 
in the sample, which may or not include 
the cases.
If cases are rare, case-popula-
tion ratio can be simplified to ad/bc/
((1−Pexp)/(1−Cexp)), where Pexp is the 
population exposure to the drug of inter-
est (b/b+d), and Cexp is the case expo-
sure to the drug of interest (a/a+c). the 
smaller the population and case expo-
sures, the better case-population ratio 
(CPr) approximates the Or. the Or 
estimates the rr when the event is rare, 
so the lower the exposure in cases and in 
the general population, and the rarer the 
event, the better the CPr approximates 
the real rr of the association of expo-
sure and event.
We built a table of CPr for various 
rr and population exposures (etable, 
http://links.lww.com/eDe/A718). When 
population exposure is below 1%, the 
difference between case-population 
ratio and actual Or or rr is less than 
1%. Above 1%, CPr underestimates rr 
above 1 and overestimates rr below 1.
We tested this in a case-population 
study of liver transplantation in europe for 
which drug utilization was the exposure 
of interest.3–5 In this study with exhaus-
tive case identification, and full descrip-
tion of the country’s drug utilization over 
the same period and in the same popula-
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To the Editor:
The usual designs to assess the rela-tionship between exposure and 
outcome are cohort studies, result-
ing in relative risks (rrs), and case-
control studies, resulting in odds ratios 
(Ors). traditionally case-control stud-
ies are preferred when events are rare, 
and cohort studies when exposures are 
uncommon. When both events and 
exposures are rare, there is a particular 
challenge. In such settings, the case- 
population approach might be of help.
Case-population studies com-
pare exposure in cases and in the gen-
eral population.1,2 this design requires 
exhaustive or representative collation of 
cases of interest in a given territory and 
a measure of exposure to the exposure 
of interest in the territory’s population. 
Denominator is person-time,2 or num-
ber of exposed subjects.3 the metric 
is the case-population ratio, the ratio 
of exposure in cases and in the general 
population.
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